Skip to Content

Eaton Vance Worldwide Health Sci I EIHSX

Medalist Rating as of | See Eaton Vance Investment Hub
  • NAV / 1-Day Return 12.96  /  0.08 %
  • Total Assets 953.5 Mil
  • Adj. Expense Ratio
    0.960%
  • Expense Ratio 0.960%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 1,000,000
  • Status Open
  • TTM Yield 0.44%
  • Turnover 21%

Morningstar’s Analysis EIHSX

Will EIHSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A decent global healthcare vehicle for the long haul.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Eaton Vance Worldwide Health Sciences remains a solid source of global exposure to healthcare stocks rather than an outstanding one. The strategy retains its People and Process ratings of Average.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings EIHSX

  • Current Portfolio Date
  • Equity Holdings 42
  • Bond Holdings 0
  • Other Holdings 4
  • % Assets in Top 10 Holdings 52.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
8.96
81,423,865
Healthcare
8.41
76,420,737
Healthcare
6.28
57,063,168
Healthcare
4.92
44,691,235
Healthcare
4.85
44,095,960
Healthcare
4.18
38,025,611
Healthcare
4.03
36,604,293
Healthcare
3.68
33,479,596
Healthcare
3.45
31,372,101
Healthcare
3.40
30,937,494
Healthcare